{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:42:31Z","timestamp":1794444151381,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01959-x","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T05:15:38Z","timestamp":1772514938000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Gut microbiota, a new approach to management of polycystic ovary syndrome: a systematic review, meta-analysis and meta-evidence of 26 randomized controlled trials"],"prefix":"10.1186","volume":"19","author":[{"given":"Tong","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanfeng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juewei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaizhi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangwen","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"issue":"9","key":"1959_CR1","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","volume":"10","author":"AE Joham","year":"2022","unstructured":"Joham AE, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10(9):668\u201380.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"1959_CR2","doi-asserted-by":"publisher","first-page":"8229","DOI":"10.1038\/s41598-024-58064-0","volume":"14","author":"G Pratama","year":"2024","unstructured":"Pratama G, et al. Mechanism of elevated LH\/FSH ratio in lean PCOS revisited: a path analysis. Sci Rep. 2024;14(1):8229.","journal-title":"Sci Rep"},{"key":"1959_CR3","doi-asserted-by":"crossref","unstructured":"Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. Int J Women\u2019s Health. 2011;3:25\u201335.","DOI":"10.2147\/IJWH.S11304"},{"issue":"4","key":"1959_CR4","doi-asserted-by":"publisher","first-page":"e0153196","DOI":"10.1371\/journal.pone.0153196","volume":"11","author":"Y Guo","year":"2016","unstructured":"Guo Y, et al. Association between polycystic ovary syndrome and gut microbiota. PLoS One. 2016;11(4):e0153196.","journal-title":"PLoS One"},{"issue":"1","key":"1959_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13048-020-00670-3","volume":"13","author":"F-f He","year":"2020","unstructured":"He F-f, Li Y-m. Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review. J Ovarian Res. 2020;13(1):73.","journal-title":"J Ovarian Res"},{"issue":"2","key":"1959_CR6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1089\/met.2006.4.122","volume":"4","author":"\u0130 Tarkun","year":"2006","unstructured":"Tarkun \u0130, et al. Association between Circulating tumor necrosis factor-alpha, interleukin-6, and insulin resistance in normal-weight women with polycystic ovary syndrome. Metab Syndr Relat Disord. 2006;4(2):122\u20138.","journal-title":"Metab Syndr Relat Disord"},{"issue":"8","key":"1959_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","volume":"14","author":"GR Gibson","year":"2017","unstructured":"Gibson GR, et al. Expert consensus document: the international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Reviews Gastroenterol Hepatol. 2017;14(8):491\u2013502.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"1959_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2014.66","author":"C Hill","year":"2014","unstructured":"Hill C, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature reviews Gastroenterology & hepatology. 2014. https:\/\/doi.org\/10.1038\/nrgastro.2014.66.","journal-title":"Nature reviews Gastroenterology & hepatology"},{"issue":"1","key":"1959_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408398.2020.1854675","volume":"62","author":"Y Yao","year":"2022","unstructured":"Yao Y, et al. The role of short-chain fatty acids in immunity, inflammation and metabolism. Crit Rev Food Sci Nutr. 2022;62(1):1\u201312.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1959_CR10","unstructured":"Higgins JPT et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.4. 2023 (updated August 2023)."},{"key":"1959_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jclinepi.2021.09.021","volume":"141","author":"S Minozzi","year":"2022","unstructured":"Minozzi S, et al. Reliability of the revised Cochrane risk-of-bias tool for randomised trials (RoB2) improved with the use of implementation instruction. J Clin Epidemiol. 2022;141:99\u2013105.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"1959_CR12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, et al. GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"1959_CR13","doi-asserted-by":"publisher","first-page":"11349","DOI":"10.4088\/JCP.20f13681","volume":"81","author":"C Andrade","year":"2020","unstructured":"Andrade C. Mean difference, standardized mean difference (SMD), and their use in meta-analysis: as simple as it gets. J Clin Psychiatry. 2020;81(5):11349.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"1959_CR14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/0272-4332.00039","volume":"22","author":"H Christopher Frey","year":"2002","unstructured":"Christopher Frey H, Patil SR. Identification and review of sensitivity analysis methods. Risk Anal. 2002;22(3):553\u201378.","journal-title":"Risk Anal"},{"issue":"7109","key":"1959_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"E Matthias","year":"1997","unstructured":"Matthias E, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629.","journal-title":"BMJ"},{"key":"1959_CR16","doi-asserted-by":"crossref","unstructured":"ESHRE, T.R. and A.-S.P.C.W. Group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility Sterility. 2004;81(1):19\u201325.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"issue":"1","key":"1959_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/cen.13333","volume":"87","author":"F Foroozanfard","year":"2017","unstructured":"Foroozanfard F, et al. The effects of dietary approaches to stop hypertension diet on weight loss, anti-Mullerian hormone and metabolic profiles in women with polycystic ovary syndrome: A randomized clinical trial. Clin Endocrinol. 2017;87(1):51\u20138.","journal-title":"Clin Endocrinol"},{"issue":"1","key":"1959_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12902-018-0248-0","volume":"18","author":"K Nasri","year":"2018","unstructured":"Nasri K, et al. The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. BMC Endocr Disorders. 2018;18(1):21.","journal-title":"BMC Endocr Disorders"},{"issue":"3","key":"1959_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/cen.14712","volume":"97","author":"R Ziaei","year":"2022","unstructured":"Ziaei R, et al. Effects of inulin-type Fructans with different degrees of polymerization on inflammation, oxidative stress and endothelial dysfunction in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Clin Endocrinol. 2022;97(3):319\u201330.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"1959_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.numecd.2018.07.002","volume":"29","author":"Z Esmaeilinezhad","year":"2019","unstructured":"Esmaeilinezhad Z, et al. Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS: A randomized, triple blind, controlled trial. Nutr Metabolism Cardiovasc Dis. 2019;29(2):201\u20138.","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"issue":"2","key":"1959_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00404-024-07833-3","volume":"311","author":"I Chudzicka-Struga\u0142a","year":"2025","unstructured":"Chudzicka-Struga\u0142a I, et al. Six-month randomized, placebo controlled trial of synbiotic supplementation in women with polycystic ovary syndrome undergoing lifestyle modifications. Arch Gynecol Obstet. 2025;311(2):499\u2013506.","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"1959_CR22","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s12602-018-9405-z","volume":"11","author":"M Samimi","year":"2019","unstructured":"Samimi M, et al. The effects of synbiotic supplementation on metabolic status in women with polycystic ovary syndrome: a randomized double-blind clinical trial. Probiotics Antimicrob Proteins. 2019;11(4):1355\u201361.","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"1","key":"1959_CR23","first-page":"51","volume":"15","author":"S Darvishi","year":"2021","unstructured":"Darvishi S, et al. Synbiotic supplementation improves metabolic factors and obesity values in women with polycystic ovary syndrome independent of affecting Apelin levels: a randomized double-blind placebo-controlled clinical trial. Int J Fertility Steril. 2021;15(1):51.","journal-title":"Int J Fertility Steril"},{"issue":"1","key":"1959_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12944-020-01244-4","volume":"19","author":"E Karimi","year":"2020","unstructured":"Karimi E, et al. The effect of synbiotics supplementation on anthropometric indicators and lipid profiles in women with polycystic ovary syndrome: a randomized controlled trial. Lipids Health Dis. 2020;19(1):60.","journal-title":"Lipids Health Dis"},{"issue":"13","key":"1959_CR25","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2174\/138161209788168164","volume":"15","author":"PD Cani","year":"2009","unstructured":"Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des. 2009;15(13):1546\u201358.","journal-title":"Curr Pharm Des"},{"issue":"8","key":"1959_CR26","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1017\/S0007114516003457","volume":"116","author":"S Ahmadi","year":"2016","unstructured":"Ahmadi S, et al. The effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes: a randomised, double-blind, placebo-controlled trial. Br J Nutr. 2016;116(8):1394\u2013401.","journal-title":"Br J Nutr"},{"issue":"9","key":"1959_CR27","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.3390\/nu13093211","volume":"13","author":"H-Y Li","year":"2021","unstructured":"Li H-Y, et al. Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics on metabolic diseases targeting gut microbiota: A narrative review. Nutrients. 2021;13(9):3211.","journal-title":"Nutrients"},{"key":"1959_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013097","author":"TL Berentzen","year":"2010","unstructured":"Berentzen TL, et al. Changes in waist circumference and mortality in middle-aged men and women. PLoS One. 2010. https:\/\/doi.org\/10.1371\/journal.pone.0013097.","journal-title":"PLoS One"},{"issue":"2","key":"1959_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","volume":"5","author":"L Ding","year":"2015","unstructured":"Ding L, et al. Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharm Sinica B. 2015;5(2):135\u201344.","journal-title":"Acta Pharm Sinica B"},{"issue":"12","key":"1959_CR30","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1002\/oby.20428","volume":"21","author":"SR Yoo","year":"2013","unstructured":"Yoo SR, et al. Probiotics L. plantarum and L. curvatus in combination alter hepatic lipid metabolism and suppress diet-induced obesity. Obesity. 2013;21(12):2571\u20138.","journal-title":"Obesity"},{"key":"1959_CR31","doi-asserted-by":"publisher","first-page":"105074","DOI":"10.1016\/j.jff.2022.105074","volume":"92","author":"MA Farhangi","year":"2022","unstructured":"Farhangi MA, et al. Effectiveness of omega-3 and prebiotics on adiponectin, leptin, liver enzymes lipid profile and anthropometric indices in patients with non-alcoholic fatty liver disease: a randomized controlled trial. J Funct Foods. 2022;92:105074.","journal-title":"J Funct Foods"},{"key":"1959_CR32","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1007\/s00394-020-02233-0","volume":"59","author":"M Cozzolino","year":"2020","unstructured":"Cozzolino M, et al. Therapy with probiotics and synbiotics for polycystic ovarian syndrome: a systematic review and meta-analysis. Eur J Nutr. 2020;59:2841\u201356.","journal-title":"Eur J Nutr"},{"key":"1959_CR33","doi-asserted-by":"publisher","first-page":"1121541","DOI":"10.3389\/fnut.2023.1121541","volume":"10","author":"V Musazadeh","year":"2023","unstructured":"Musazadeh V, et al. Effects of synbiotics supplementation on anthropometric and lipid profile parameters: finding from an umbrella meta-analysis. Front Nutr. 2023;10:1121541.","journal-title":"Front Nutr"},{"issue":"7","key":"1959_CR34","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s11745-014-3901-z","volume":"49","author":"H Shakeri","year":"2014","unstructured":"Shakeri H, et al. Consumption of synbiotic bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type-2 diabetes. Lipids. 2014;49(7):695\u2013701.","journal-title":"Lipids"},{"issue":"1","key":"1959_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.intimp.2012.10.026","volume":"15","author":"Y Wang","year":"2013","unstructured":"Wang Y, et al. Protective effects of probiotic Lactobacillus casei Zhang against endotoxin- and d-galactosamine-induced liver injury in rats via anti-oxidative and anti-inflammatory capacities. Int Immunopharmacol. 2013;15(1):30\u20137.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"1959_CR36","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1365-2249.2007.03587.x","volume":"151","author":"M Schlee","year":"2008","unstructured":"Schlee M, et al. Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin Exp Immunol. 2008;151(3):528\u201335.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"1959_CR37","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4161\/gmic.1.3.11712","volume":"1","author":"CM Thomas","year":"2010","unstructured":"Thomas CM, Versalovic J. Probiotics-host communication: modulation of signaling pathways in the intestine. Gut Microbes. 2010;1(3):148\u201363.","journal-title":"Gut Microbes"},{"issue":"5","key":"1959_CR38","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/mnfr.201300497","volume":"58","author":"F Capit\u00e1n-Ca\u00f1adas","year":"2014","unstructured":"Capit\u00e1n-Ca\u00f1adas F, et al. Prebiotic oligosaccharides directly modulate Proinflammatory cytokine production in monocytes via activation of TLR4. Mol Nutr Food Res. 2014;58(5):1098\u2013110.","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"1959_CR39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00394-019-02033-1","volume":"59","author":"SG Shamasbi","year":"2020","unstructured":"Shamasbi SG, Ghanbari-Homayi S, Mirghafourvand M. The effect of probiotics, prebiotics, and synbiotics on hormonal and inflammatory indices in women with polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Nutr. 2020;59(2):433\u201350.","journal-title":"Eur J Nutr"},{"issue":"1","key":"1959_CR40","first-page":"51","volume":"15","author":"S Darvishi","year":"2021","unstructured":"Darvishi S, et al. Synbiotic supplementation improves metabolic factors and obesity values in women with polycystic ovary syndrome independent of affecting Apelin levels: A randomized Double-Blind Placebo - Controlled clinical trial. Int J Fertility Steril. 2021;15(1):51\u20139.","journal-title":"Int J Fertility Steril"},{"key":"1959_CR41","doi-asserted-by":"publisher","unstructured":"Karimi E, et al. Erratum: Effects of synbiotic supplementation on metabolic parameters and apelin in women with polycystic ovary syndrome: A randomised double-blind placebo-controlled trial (British Journal of Nutrition). British J Nutr. 2018;124(4):479. https:\/\/doi.org\/10.1017\/S0007114517003920.","DOI":"10.1017\/S0007114517003920"},{"key":"1959_CR42","doi-asserted-by":"crossref","unstructured":"Esmaeilinezhad Z, et al. The effect of synbiotics pomegranate juice on cardiovascular risk factors in PCOS patients: a randomized, triple-blinded, controlled trial. Journal of endocrinological investigation. 2020;43(4):539\u2013548.","DOI":"10.1007\/s40618-019-01139-x"},{"key":"1959_CR43","doi-asserted-by":"crossref","unstructured":"Gholizadeh Shamasbi S, et al. The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: a randomized, triple-blind, controlled, clinical trial. European journal of nutrition. 2019;58(2):629\u2013640.","DOI":"10.1007\/s00394-018-1648-7"},{"key":"1959_CR44","unstructured":"Shamasbi SG, et al. Effect of prebiotic on anthropometric indices in women with polycystic ovarian syndrome: a triple-blind, randomized, controlled clinical trial. Iran Red Crescent Med J. 2018;20:e67270."},{"key":"1959_CR45","doi-asserted-by":"crossref","unstructured":"Hariri Z, et al. Effects of Synbiotic-Containing Bacillus coagulans (GBI-30) on the Cardiovascular Status of patients with polycystic ovary syndrome: a Triple-blinded, randomized, placebo-controlled study. Clinical Therapeutics. 2023;45(10):e193\u2013e199.","DOI":"10.1016\/j.clinthera.2023.07.024"},{"key":"1959_CR46","unstructured":"Pourbehi F, et al., Effect of psyllium supplementation on insulin resistance and lipid profile in non-diabetic women with polycystic ovary syndrome: a randomized placebo-controlled trial. 2020."},{"key":"1959_CR48","unstructured":"Ye C, Ming-hui Z, and Chan-ni W. Effect of probiotic supplementation on blood sugar and lipids in patients with polycystic ovary syndrome. Journal of International Obstetrics and Gynecology. 2018;45(2):199."},{"key":"1959_CR49","doi-asserted-by":"crossref","unstructured":"Ghanei N, et al. The probiotic supplementation reduced inflammation in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Journal of functional foods. 2018;42:306\u2013311.","DOI":"10.1016\/j.jff.2017.12.047"},{"key":"1959_CR50","doi-asserted-by":"crossref","unstructured":"Jamilian M, et al. The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome. Journal of ovarian research. 2018;11(1):80.","DOI":"10.1186\/s13048-018-0457-1"},{"key":"1959_CR51","unstructured":"Karamali M, Samimi M, Bahmani F, Foroozanfard F, Esmaillzadeh A. The effects of DASH diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomised clinical trial. Human reproduction (Oxford, England). 2014;29:i315\u2013i316."},{"key":"1959_CR52","doi-asserted-by":"crossref","unstructured":"Ostadmohammadi V, et al. Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome. Journal of ovarian research. 2019;12(1):5.","DOI":"10.1186\/s13048-019-0480-x"},{"key":"1959_CR53","doi-asserted-by":"crossref","unstructured":"Shoaei T, et al. Effects of probiotic supplementation on pancreatic \u03b2-cell function and c-reactive protein in women with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial. International journal of preventive medicine. 2015;6(1):27.","DOI":"10.4103\/2008-7802.153866"},{"key":"1959_CR54","unstructured":"Zhu XX, Xia PB, He YQ. Effects of vitamin D and probiotics supplementation on bacterial diversity, metabolism and hormone level in patients with polycystic ovary syndrome. 2021."},{"key":"1959_CR55","doi-asserted-by":"crossref","unstructured":"Kaur I. et al. Efficacy of multi-strain probiotic along with dietary and lifestyle modifications on polycystic ovary syndrome: a randomised, double-blind placebo-controlled study. European Journal of Nutrition. 2022;61(8):4145\u201354.","DOI":"10.1007\/s00394-022-02959-z"},{"key":"1959_CR56","doi-asserted-by":"crossref","unstructured":"Arab A, et al. Effects of probiotic supplementation on hormonal and clinical outcomes of women diagnosed with polycystic ovary syndrome: A double-blind, randomized, placebo-controlled clinical trial. Journal of Functional Foods. 2022;96:105203.","DOI":"10.1016\/j.jff.2022.105203"},{"key":"1959_CR58","doi-asserted-by":"crossref","unstructured":"Szyd\u0142owska I, et al. Changes in Hormonal Profile and Body Mass Index in Women with Polycystic Ovary Syndrome After Probiotic Intake: A 12-Week Placebo-Controlled and Randomized Clinical Study. Nutrients. 2025;17(3):405.","DOI":"10.3390\/nu17030405"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01959-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01959-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01959-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:58:02Z","timestamp":1772715482000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-025-01959-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1959"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01959-x","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"5 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}